Prescription drug · ANDA
Donepezil Hydrochloride NDC 71205-948
Donepezil hydrochloride 23 mg/1 · Tablet, Film coated · Oral · Proficient Rx LP
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71205-948-00 | 71205094800 | 100 TABLET, FILM COATED in 1 BOTTLE (71205-948-00)Marketed from Nov 19, 2020 | |
| 71205-948-30 | 71205094830 | 30 TABLET, FILM COATED in 1 BOTTLE (71205-948-30)Marketed from Nov 19, 2020 | |
| 71205-948-55 | 71205094855 | 500 TABLET, FILM COATED in 1 BOTTLE (71205-948-55)Marketed from Nov 19, 2020 | |
| 71205-948-60 | 71205094860 | 60 TABLET, FILM COATED in 1 BOTTLE (71205-948-60)Marketed from Nov 19, 2020 | |
| 71205-948-90 | 71205094890 | 90 TABLET, FILM COATED in 1 BOTTLE (71205-948-90)Marketed from Nov 19, 2020 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Donepezil Hydrochloride
- Generic name (nonproprietary)
- donepezil hydrochloride
- Active ingredients
- Donepezil hydrochloride — 23 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Proficient Rx LP
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 203104
- Marketing start
- Listing expires
- Other FDA classes
- Cholinesterase Inhibitors (Mechanism)
- Identifiers
- Product ID 71205-948_b974cd85-fbe8-40e4-89a7-b6c6845172e1SPL ID b974cd85-fbe8-40e4-89a7-b6c6845172e1SPL set ID 32709bda-53d0-4d57-9f0b-3e1f28e39f25RxCUI 1100184UNII 3O2T2PJ89DUPC 0371205948306
- Pharmacologic class
- Cholinesterase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471205094800followed by a unit qualifier and the quantityPackage 71205-0948-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Donepezil hydrochloride tablets are indicated for the treatment of dementia of the Alzheimer’s type. Efficacy has been demonstrated in patients with mild, moderate, and severe Alzheimer’s disease. Donepezil hydrochloride tablets are acetylcholinesterase inhibitor indicated for the treatment of dementia of the Alzheimer’s type. Efficacy has been demonstrated in patients with mild, moderate, and severe Alzheimer’s Disease ( 1 )
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 203104
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Donepezil Hydrochloride | Donepezil hydrochloride 23 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 72162-1276 |
| Donepezil Hydrochloride | Donepezil hydrochloride 23 mg/1 | Tablet, Film coatedOral | Upsher-Smith Laboratories, LLC | 24979-004 |
| Donepezil Hydrochloride | Donepezil hydrochloride 23 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 63629-8483 |
| Donepezil Hydrochloride | Donepezil hydrochloride 23 mg/1 | Tablet, Film coatedOral | Golden State Medical Supply, Inc. | 51407-320 |